CDKN2B-AS1, CDKN2B antisense RNA 1, 100048912

N. diseases: 11; N. variants: 168
Source: CURATED ×
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C0014175
Disease: Endometriosis
Endometriosis
disease Female Urogenital Diseases and Pregnancy Complications Disease or Syndrome 161 80 0.450 None 1.000 1 2 2010 2017
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma
disease Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases Neoplastic Process 22 174 0.430 None 1.000 1 2 2010 2018
CUI: C0017612
Disease: Glaucoma, Open-Angle
Glaucoma, Open-Angle
disease Eye Diseases Disease or Syndrome 12 210 0.430 None 1.000 1 97 2011 2018
CUI: C0153381
Disease: Malignant neoplasm of mouth
Malignant neoplasm of mouth
group Neoplasms; Stomatognathic Diseases Neoplastic Process 54 13 0.420 None 1.000 1 1 2016 2018
CUI: C0339573
Disease: Glaucoma, Primary Open Angle
Glaucoma, Primary Open Angle
disease Eye Diseases Disease or Syndrome 13 18 0.400 None 1.000 1 2011 2018
CUI: C0023434
Disease: Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
disease Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases Neoplastic Process 55 183 0.300 None 1.000 1 2013 2013
CUI: C0026640
Disease: Mouth Neoplasms
Mouth Neoplasms
group Neoplasms; Stomatognathic Diseases Neoplastic Process 54 0.300 None 1.000 1 2016 2016
CUI: C0271148
Disease: Secondary Open Angle Glaucoma
Secondary Open Angle Glaucoma
disease Eye Diseases Disease or Syndrome 12 0.300 None 1.000 1 2011 2011
CUI: C0333704
Disease: Chromosome Breaks
Chromosome Breaks
phenotype Pathological Conditions, Signs and Symptoms Cell or Molecular Dysfunction 14 0.300 None 1.000 1 2017 2017
CUI: C0376628
Disease: Chromosome Breakage
Chromosome Breakage
phenotype Pathological Conditions, Signs and Symptoms Cell or Molecular Dysfunction 14 0.300 None 1.000 1 2017 2017
CUI: C0269102
Disease: Endometrioma
Endometrioma
disease Female Urogenital Diseases and Pregnancy Complications Neoplastic Process 161 0.300 None 1.000 1 2010 2010